CD8A and graft versus host disease: In contrast, GVHD-related mortality was higher in the CD8+high28-group compared to the CD8+low28-group, 34.8% (8 patients) vs. 7.7% of deaths (1 patient), respectively (HR = 6.40, P = 0.100).